Also, consistent with ChIP-Seq data (Figure 3d), NANOG bound to an enhancer of IGFBP5 (Figure 7b), a known AR target gene, in LNCaP AD cells but the binding was reduced in AI cells (Figure 7c). This evidence concerns the gene IGFBP5 and Alzheimer disease.